| 2021-11-10 | +26.8% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2025-08-07 | +20.8% | earnings | Seeking Alpha | KORU Medical Systems raises 2025 revenue outlook to $39.5M–$40.5M with accelerating international growth and new drug pipeline milestones |
| 2025-08-07 | +20.8% | earnings | Seeking Alpha | KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript |
| 2025-05-07 | +19.0% | earnings | Seeking Alpha | KORU Medical Systems Non-GAAP EPS of $0.00 beats by $0.03, revenue of $9.6M beats by $0.74M |
| 2025-05-07 | +19.0% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2025-11-12 | +18.2% | earnings | Seeking Alpha | KORU Medical Systems Non-GAAP EPS of $0.00 beats by $0.02, revenue of $10.4M beats by $0.73M |
| 2025-11-12 | +18.2% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2025-08-06 | +17.3% | earnings | Seeking Alpha | KORU Medical Systems GAAP EPS of $0.00 beats by $0.03, revenue of $10.2M beats by $0.74M |
| 2025-08-06 | +17.3% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2021-05-12 | +17.1% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2025-11-25 | +17.0% | legal | SEC EDGAR | KRMD 8-K: 1.01 and (SEC Filing) |
| 2024-08-08 | +16.5% | earnings | Seeking Alpha | KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Transcript |
| 2025-03-13 | -16.3% | earnings | Seeking Alpha | KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript |
| 2025-03-13 | -16.3% | earnings | Seeking Alpha | KORU Medical Systems, Inc. 2024 Q4 - Results - Earnings Call Presentation |
| 2025-11-13 | +16.0% | earnings | Seeking Alpha | KORU Medical Systems projects 20%–22% revenue growth for 2025 while advancing oncology and international expansion |
| 2025-11-13 | +16.0% | earnings | Seeking Alpha | KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript |
| 2022-11-09 | +13.6% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2025-02-14 | -12.9% | analyst | Seeking Alpha | KORU downgraded by Piper Sandler on valuation |
| 2025-03-12 | -12.4% | earnings | Seeking Alpha | KORU Medical Systems Non-GAAP EPS of -$0.02 in-line, revenue of $8.84M misses by $0.05M |
| 2025-03-12 | -12.4% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2023-11-08 | -11.4% | legal | SEC EDGAR | KRMD 8-K: 2.02, 5.02, 8.01 (SEC Filing) |
| 2024-08-07 | +9.1% | news | Seeking Alpha | KORU Medical Systems raises FY outlook |
| 2024-08-07 | +9.1% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2024-08-07 | +9.1% | earnings | Stock Titan | KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance - Stock Titan |
| 2024-05-01 | +9.1% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2024-03-27 | +8.9% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2023-03-08 | -8.1% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2025-04-07 | -7.9% | legal | SEC EDGAR | KRMD 8-K: 5.02 and 7.01 (SEC Filing) |
| 2024-11-20 | +7.6% | news | Investing.com | KRMD stock touches 52-week high at $3.41 amid robust growth - Investing.com |
| 2022-03-02 | -7.3% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2021-08-11 | -5.7% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2023-06-27 | -5.3% | legal | SEC EDGAR | KRMD 8-K: 5.02, 8.01 (SEC Filing) |
| 2025-11-15 | +4.9% | earnings | Seeking Alpha | KORU Medical Systems, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2024-03-13 | +4.6% | legal | SEC EDGAR | KRMD 8-K: 1.01, 2.02, 2.03, 3.02 (SEC Filing) |
| 2023-05-17 | -4.5% | legal | SEC EDGAR | KRMD 8-K: 1.01, 3.03, 5.02, 5.03, 5.07, 8.01 (SEC Filing) |
| 2024-11-13 | +4.3% | earnings | Seeking Alpha | KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript |
| 2024-11-13 | +4.3% | earnings | Seeking Alpha | KORU Medical Systems, Inc. 2024 Q3 - Results - Earnings Call Presentation |
| 2024-11-13 | +4.3% | earnings | Seeking Alpha | KORU Medical Systems Non-GAAP EPS of -$0.03 beats by $0.01, revenue of $8.2M beats by $0.49M |
| 2024-11-13 | +4.3% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2025-02-07 | -3.9% | expansion | Seeking Alpha | KORU Medical Systems signs agreement for subcutaneous immunoglobulin infusion system |
| 2026-03-20 | +3.7% | news | Zacks | Phreesia (PHR) Stock Jumps 5.1%: Will It Continue to Soar? |
| 2025-04-04 | -3.3% | legal | SEC EDGAR | KRMD 8-K: 1.01 and (SEC Filing) |
| 2023-05-04 | -3.1% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2026-03-12 | -3.0% | earnings | Zacks | KORU Medical Systems, Inc. (KRMD) Reports Q4 Loss, Beats Revenue Estimates |
| 2026-03-12 | -3.0% | executive | Business Wire | KORU Medical Systems Announces CEO Transition |
| 2026-03-12 | -3.0% | earnings | Business Wire | KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance |
| 2026-03-12 | -3.0% | earnings | Seeking Alpha | Koru medical systems targets $47.5M–$50M revenue in 2026 as leadership transitions and international expansion accelerate |
| 2026-03-12 | -3.0% | earnings | Seeking Alpha | KORU Medical Systems, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-03-12 | -3.0% | earnings | Seeking Alpha | KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript |
| 2026-03-12 | -3.0% | executive | Seeking Alpha | KORU Medical Systems CEO Linda Tharby to retire |
| 2026-03-12 | -3.0% | earnings | Seeking Alpha | KORU Medical Systems reports Q4 results |
| 2026-03-12 | -3.0% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2026-03-12 | -3.0% | earnings | MarketBeat | KORU Medical Systems Q4 2025 Earnings Call Transcript - MarketBeat |
| 2026-03-12 | -3.0% | executive | Stock Titan | KORU CEO who doubled patient base to 55,000 hands role to successor - Stock Titan |
| 2025-07-02 | -2.9% | legal | Stock Titan | KRMD SEC Filings - Koru Med Sys 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2024-11-06 | -2.7% | news | Seeking Alpha | Impressive Turnaround At KORU Medical |
| 2026-03-17 | +2.5% | legal | Zacks | KORU Medical Secures EU MDR Certification for Freedom60 Infusion Pump |
| 2025-01-13 | +2.5% | earnings | Seeking Alpha | KORU Medical Systems reports record Q4 and FY24 revenue |
| 2025-01-13 | +2.5% | legal | SEC EDGAR | KRMD 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-06 | -2.4% | news | Stock Titan | Major KRMD holder Horton Capital fund granted 3,472 KORU Medical shares - Stock Titan |
| 2026-01-12 | +2.3% | earnings | Seeking Alpha | KORU Medical Systems sees Q4 revenue of $10.9M |
| 2026-01-12 | +2.3% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2026-01-12 | +2.3% | news | Stock Titan | Medical device maker reports record sales and 2025 cash flowing in - Stock Titan |
| 2024-04-11 | -2.2% | legal | SEC EDGAR | KRMD 8-K: 8.01 and (SEC Filing) |
| 2024-04-11 | -2.2% | news | Stock Titan | KORU Medical Systems Announces Successful Appeal in EU Notified Body Review - Stock Titan |
| 2023-08-02 | +1.9% | legal | SEC EDGAR | KRMD 8-K: 2.02, 5.02 (SEC Filing) |
| 2023-08-09 | +1.9% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2023-08-09 | +1.9% | earnings | MarketBeat | KORU Medical Systems Q2 2023 Earnings Call Transcript - MarketBeat |
| 2026-04-03 | -1.9% | legal | SEC EDGAR | KRMD 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-04-03 | -1.9% | news | TipRanks | REPRO-MED Systems Amends Credit Facility to Enhance Flexibility - TipRanks |
| 2026-04-03 | -1.9% | news | Stock Titan | Debt terms eased as KORU Medical (NASDAQ: KRMD) extends credit facility - Stock Titan |
| 2026-01-29 | -1.9% | legal | Stock Titan | FDA clears KORU device to deliver RYSTIGGO for rare autoimmune disorder - Stock Titan |
| 2024-08-21 | -1.8% | legal | SEC EDGAR | KRMD 8-K: 5.02 and (SEC Filing) |
| 2025-04-08 | -1.8% | news | Investing.com | KRMD stock touches 52-week low at $2.04 amid market challenges - Investing.com |
| 2024-07-24 | -1.6% | legal | SEC EDGAR | KRMD 8-K: 1.01, 5.02 (SEC Filing) |
| 2024-07-24 | -1.6% | news | Stock Titan | KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda - Stock Titan |
| 2026-03-16 | -1.5% | legal | SEC EDGAR | KRMD 8-K: 5.02 and (SEC Filing) |
| 2026-01-04 | -1.4% | news | Stock Titan | KORU Medical (KRMD) chair granted 5,208 shares at $4.32 - Stock Titan |
| 2022-07-06 | +1.0% | legal | SEC EDGAR | KRMD 8-K: 1.01, 2.03 (SEC Filing) |
| 2022-05-18 | +0.9% | legal | SEC EDGAR | KRMD 8-K: 1.01, 5.02 (SEC Filing) |
| 2026-03-13 | -0.9% | earnings | Moby | KORU Medical Systems, Inc. Q4 2025 Earnings Call Summary |
| 2026-03-13 | -0.9% | news | Business Wire | KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility |
| 2026-03-13 | -0.9% | earnings | GuruFocus.com | KORU Medical Systems Inc (KRMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... |
| 2026-03-13 | -0.9% | earnings | MarketBeat | KORU Medical Systems Q4 Earnings Call Highlights |
| 2022-05-04 | -0.9% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2026-03-26 | -0.8% | legal | Stock Titan | KRMD SEC Filings - Koru Med Sys 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-04-01 | -0.8% | news | Stock Titan | Director at KORU Medical Systems (KRMD) receives stock grant - Stock Titan |
| 2026-04-01 | -0.8% | news | Stock Titan | Donna French of KORU Medical Systems (KRMD) receives 3,472-share stock grant - Stock Titan |
| 2026-04-01 | -0.8% | news | Stock Titan | Director Matin Shahriar receives 3,472 KRMD shares in equity grant at KORU Medical (KRMD) - Stock Titan |
| 2026-04-01 | -0.8% | news | Stock Titan | Director Edward Wholihan receives 3,472 KRMD shares in Form 4 award - Stock Titan |
| 2024-02-04 | +0.8% | analyst | TradingView | KRMD Forecast — Price Target — Prediction for 2027 - TradingView |
| 2026-03-14 | -0.8% | legal | The Globe and Mail | B. Riley Securities Remains a Buy on REPRO-MED Systems (KRMD) - The Globe and Mail |
| 2022-08-03 | +0.8% | legal | SEC EDGAR | KRMD 8-K: 2.02 and (SEC Filing) |
| 2026-04-16 | +0.4% | news | Business Wire | KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026 |
| 2026-04-16 | +0.4% | earnings | Stock Titan | KORU Medical to hold Q1 results call May 6 at 4:30 p.m. ET - Stock Titan |
| 2026-02-14 | -0.2% | news | Stock Titan | KRMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan |
| 2025-05-11 | -0.1% | earnings | Seeking Alpha | KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript |
| 2025-05-11 | -0.1% | earnings | Seeking Alpha | KORU Medical Systems, Inc. 2025 Q1 - Results - Earnings Call Presentation |
| 2025-06-11 | -0.1% | news | Seeking Alpha | KORU Medical Systems to join Russell 3000 and 2000 indexes |
| 2025-02-10 | -0.1% | news | Seeking Alpha | KORU Medical Systems Has A Long Runway |
| 2023-10-04 | +0.1% | legal | SEC EDGAR | KRMD 8-K: 5.02, 8.01 (SEC Filing) |
| 2026-04-09 | -0.0% | news | Stock Titan | KORU Medical (KRMD) plans 2026 shareholder votes and doubles equity incentive pool - Stock Titan |